Home
Scholarly Works
Phase II study of bortezomib in advanced or...
Journal article

Phase II study of bortezomib in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital [PMH] Phase II Consortium

Authors

Sridhar SS; Stadler W; Le L; Hedley D; Pond G; Wright J; Vokes E; Thomas S; Moore M

Journal

Journal of Clinical Oncology, Vol. 23, No. 16_suppl, pp. 4677–4677

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

June 1, 2005

DOI

10.1200/jco.2005.23.16_suppl.4677

ISSN

0732-183X
View published work (Non-McMaster Users)

Contact the Experts team